Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Treatment of pellagra
Age: Adult
Dose: Oral – 300-500 mg
Frequency: daily in divided doses
Indication: Management of Hartnup disease
Age: Adult
Dose: Oral – 50-200 mg
Frequency: daily

Child Dose

Clinical InformationAdministration Information
Indication: treatment of pellagra
Age: Child
Dose: Oral – 100-300 mg
Frequency: daily in divided doses
Note: Treatment and prophylaxis of nicotinic acid deficiency
Administration
  • Take with food
  • Take at bedtime after low-fat snack
Side Effect

Drug Interaction

Drug NameRisk Factors
HMG-CoA reductase inhibitors
Increased risk of myopathy and rhabdomyolysis
Colestyramine, Colestipol
Reduced bioavailability

Disease Interaction

Disease NameRisk Factors
Significant Hepatic Dysfunction
Risk of liver toxicity
Active Peptic Ulcer
May worsen ulcer condition

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.